Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Alliance Global Partners Downgrades T2 Biosystems to Neutral

Alliance Global Partners Downgrades T2 Biosystems to Neutral

Alliance Global Partners analyst Ben Haynor downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Alliance Global Partners analyst Ben Haynor downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

Analyst Ratings

Where Mineralys Therapeutics Stands With Analysts

By Benzinga Insights

March 16, 8:00 AM

Analysts have provided the following ratings for Mineralys Therapeutics (NASDAQ:MLYS) within the last quarter: Bullish Somewhat Bullish Indifferent…

MLYS

Tesla, Apple, GameStop, Prometheus Biosciences, Cassava Sciences: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

December 7, 8:45 PM

U.S. markets continued their weak trend on Wednesday, with next week’s Federal Open Market Committee meeting beginning to weigh on investors’ minds.

AAPL

News

Tradeweb Enters Next Phase Of Partnership With BlackRock

By Benzinga Newsdesk

December 11, 9:07 AM

Aladdin users trading U.S. and European Credit to gain seamless access to Tradeweb's AllTrade® all-to-all liquidity network across institutional, wholesale and retail marketsTradeweb Markets Inc. (NASDAQ:TW), a

BLK

Trinity Industries Shares Gain Post Q2 Results

By Akanksha Bakshi

July 27, 1:50 PM

Trinity Industries Inc (NYSE:TRN) reported second-quarter FY22 revenue growth of 42.1% year-over-year to $416.8 million. Adjusted EPS improved to $0.14…

TRN

Alliance Global Partners Downgrades T2 Biosystems to Neutral

Related Posts

Where Mineralys Therapeutics Stands With Analysts

Tesla, Apple, GameStop, Prometheus Biosciences, Cassava Sciences: Why These 5 Stocks Are Drawing Investors’ Attention Today

Tradeweb Enters Next Phase Of Partnership With BlackRock

Trinity Industries Shares Gain Post Q2 Results